Relation of Sociodemographic Factors With Primary Cause of Hospitalization Among Patients With Left Ventricular Assist Devices (from the National Inpatient Sample 2012 to 2017)

https://doi.org/10.1016/j.amjcard.2022.06.047Get rights and content

Left ventricular assist devices (LVADs) are an established intervention for end-stage heart failure (HF). Rehospitalization for serious complications remains common during the continuous-flow LVAD era. Whether sociodemographic factors are associated with differences in the frequency of severe complications leading to hospitalization remains unclear. Using data from the National Inpatient Sample, we identified all hospitalizations from 2012 to 2017 of adults aged ≥18 years with previous LVAD placement. We categorized the primary cause of hospitalizations into key adverse diagnoses, including bleeding, HF, arrhythmias, LVAD complications, stroke, and a composite of device-related infection or sepsis. We assessed the association of sociodemographic markers with primary diagnoses using modified Poisson regression. We identified 62,630 hospitalizations during the study period (41% aged ≥65, 77% men, 26% Black, 5% Hispanic). Bleeding (18%), infections (15%), and HF (15%) were the most common primary diagnoses. In the multivariable analyses, gastrointestinal bleeding was more likely among older adults (relative risk [RR] 95% confidence interval [CI] 4.69 [3.57 to 6.16]; age ≥65 vs 18 to 44 years), among Black than White patients (RR 95% CI 1.17 [1.04 to 1.32]), and less likely for the highest income quartile than the lowest (RR 95% CI 0.79 [0.69 to 0.91]). Device-related infection/sepsis was also less likely for patients with higher income (RR 95% CI 0.80 [0.67 to 0.96]). Ventricular arrhythmias were less frequent diagnoses for women than men (RR 95% CI 0.59 [0.46 to 0.75]). LVADs complications were less likely in older adults than younger adults (RR 95% CI 0.70 [0.50 to 0.98]). In conclusion, after LVAD implantation, the frequency in which specific adverse events are the primary cause of rehospitalization varies significantly by sociodemographic factors. Further study is needed to determine if there are opportunities for targeted preventive measures based on sociodemographic markers.

Introduction

Left ventricular assist devices (LVADs) are an established intervention that provide mechanical circulatory support for patients with end-stage heart failure (HF).1,2 Despite improvement in outcomes after the introduction of continuous-flow LVADs (cfLVADs) in 2008,3 rehospitalization for complications remain common.4 According to recent North American data, 38.6% and 72.2% of patients receiving an LVAD are rehospitalized within 90 days and 1 year of implantation.4 Given this continued burden of rehospitalization, understanding the sociodemographic characteristics of this rehospitalized population is of great importance. Although previous studies have investigated the association of sociodemographic factors with outcomes after LVAD implantation,4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 there is a dearth of national-level data on the association of sociodemographic factors with specific causes of hospitalization, especially key severe adverse events, with significant implications for morbidity and mortality.4,18 In this study, we use hospitalization data from the National Inpatient Sample to address this gap in knowledge. We hypothesized that the frequency in which specific adverse events are the primary cause of rehospitalizations after LVAD placement differs by sociodemographic and economic markers.

Section snippets

Methods

In this retrospective cohort study, we used hospitalization data from the Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project National Inpatient Sample from January 1, 2012 to December 31, 2017. This database is an approximately 20% sample of all civilian inpatient discharges from community hospitals in the United States, regardless of payer, which can be weighted to provide national estimates of hospitalizations and is the largest such publicly available source

Results

Demographics for hospitalizations of patients with LVAD, occurring after initial device placement for each year from 2012 to 2017 are presented in Table 1. Among the 62,630 identified hospitalizations, 41% (n = 25,945) were aged ≥65 years, 77% (48,190) were men, 26% (16,015) were Black, 5% (3,145) were Hispanic, and a majority were in the lowest income quartiles (54%, 33,635 in quartile 1 and 2 combined). The vast majority of patients lived in an urban area (84%, 52,485) and were hospitalized

Discussion

In this study, we investigated the association of sociodemographic factors with the primary causes of rehospitalization among patients who had undergone previous LVAD placement. We found significant differences in the frequency of key diagnoses by sociodemographic factors, including age, gender, race/ethnicity, insurance status, and income level.

Despite significant improvements in LVAD technology, complications remain common. Previous studies have reported comparable perioperative outcomes by

Disclosures

The authors have no conflicts of interest to declare.

Acknowledgment

This study used hospitalization data from the National Inpatient Sample which is contributed to from the following state data partners: Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio,

References (29)

  • JJ Teuteberg et al.

    ADVANCE Trial Investigators. The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies

    JACC Heart Fail

    (2015)
  • KJ Clerkin et al.

    Implantable cardioverter-defibrillators in patients with a continuous-flow left ventricular assist device: an analysis of the INTERMACS Registry

    JACC Heart Fail

    (2017)
  • CW Yancy et al.

    2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines and the Heart Failure Society of America

    Circulation

    (2017)
  • MS Slaughter et al.

    Advanced heart failure treated with continuous-flow left ventricular assist device

    N Engl J Med

    (2009)
  • Cited by (2)

    This research was supported in part by the National Center for Advancing Translational Sciences (NCATS), Bethesda, Maryland, a component of the National Institutes of Health, Bethesda, Maryland, under award No. UL1TR003017.

    View full text